首页> 外文期刊>The American Journal of Cardiology >Comparison of 30-Day and Long-Term Outcomes and Hospital Complications Among Patients Aged < 75 Versus >= 75 Years With ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
【24h】

Comparison of 30-Day and Long-Term Outcomes and Hospital Complications Among Patients Aged < 75 Versus >= 75 Years With ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

机译:75岁患者患者的30天和长期成果和医院并发症的比较= 75岁,患有经皮冠状动脉干预的ST升高

获取原文
获取原文并翻译 | 示例
       

摘要

Our aim was to evaluate the mortality rate and occurrence of complications in patients aged <75 versus >= 75 years with ST-elevation myocardial infarction (STEMI). We studied 1,657 consecutive patients with STEMI hospitalized in the cardiac intensive care unit during 2008 to 2014. All patients underwent primary percutaneous intervention, of which 292 (18%) were aged >= 75 years. Patient records were evaluated for in-hospital complications, 30-day mortality, and long-term mortality over a mean period of 3.4 +/- 2.1 years. Compared with younger patients, patients aged >= 15 years had a significantly higher rate of coronary disease risk factors, prolonged symptom duration (512 +/- 640 vs 333 +/- 545 minutes, p<0.01) and door-to-balloon time (51.1 +/- 24 vs 45.6 +/- 38, p = 0.02). Patients aged >= 75 years had more in-hospital noncardiac and cardiac complications, including cardiogenic shock and arrhythmia, and had higher 30-day and long-term mortalities. Cardiogenic shock was associated with increased short- and long-term mortality in the older group but was not incremental over the noncardiogenic shock cohort. In conclusion, in patients aged >= 75 years who underwent primary percutaneous intervention for STEMI, the short- and long-term mortality rate was greater than fourfold higher compared with younger patients. (C) 2017 Elsevier Inc. All rights reserved.
机译:我们的目的是评估患者的死亡率和患者并发症的并发症与ST升高心肌梗死(STEMI)= 75岁。我们在2008年至2014年期间研究了1,657名连续患者STEMIIS Healience住院治疗心脏重症监护病房。所有患者均经过一次经皮干预,其中292(18%)均为龄> = 75岁。评估患者记录的院内并发症,30天死亡率和长期死亡率,平均3.4 +/- 2.1岁。与年轻患者相比,患者= 15年的冠状动脉疾病危险因素率明显较高,延长症状持续时间(512 +/- 640 Vs 333 +/- 545分钟,P <0.01)和门到气球时间(51.1 +/- 24 vs 45.6 +/- 38,p = 0.02)。 ≥75岁的患者患有更多的医院性非心脏和心脏并发症,包括心形成休克和心律失常,并具有更高的30天和长期死亡率。较旧的群体中的短期和长期死亡率增加,但对非诊断困难队列没有增量的血管生成休克有关。总之,与患者= 75岁的患者,与患者进行初步经皮干预,与患者相比,短期和长期死亡率大于四倍。 (c)2017年Elsevier Inc.保留所有权利。

著录项

  • 来源
    《The American Journal of Cardiology》 |2017年第12期|共5页
  • 作者单位

    Tel Aviv Univ Dept Cardiol Tel Aviv Med Ctr Sackler Fac Med Tel Aviv Israel;

    Tel Aviv Univ Dept Cardiol Tel Aviv Med Ctr Sackler Fac Med Tel Aviv Israel;

    Tel Aviv Univ Dept Cardiol Tel Aviv Med Ctr Sackler Fac Med Tel Aviv Israel;

    Tel Aviv Univ Dept Cardiol Tel Aviv Med Ctr Sackler Fac Med Tel Aviv Israel;

    Tel Aviv Univ Dept Cardiol Tel Aviv Med Ctr Sackler Fac Med Tel Aviv Israel;

    Tel Aviv Univ Dept Cardiol Tel Aviv Med Ctr Sackler Fac Med Tel Aviv Israel;

    Tel Aviv Univ Dept Cardiol Tel Aviv Med Ctr Sackler Fac Med Tel Aviv Israel;

    Tel Aviv Univ Dept Cardiol Tel Aviv Med Ctr Sackler Fac Med Tel Aviv Israel;

    NYU Sch Med Langone Med Ctr Div Cardiovasc Med New York NY USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 心脏、血管(循环系)疾病;
  • 关键词

  • 入库时间 2022-08-20 07:24:10

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号